XRTX
XRTX
NASDAQ · Pharmaceuticals

Xortx Therapeutics Inc

$1.91
-0.01 (-0.52%)
As of Sep 21, 6:06 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +2,132.5% upside
Low Target $28.32
Average Target $42.64
High Target $47.79
Current Price $1.91
Current
$1.91
Target
$42.64
$28.32 $42.64 avg $47.79
Scenario Analysis
Bear Case
$28.32
1,382.7%
Low target
Base Case
$42.64
+2,132.5%
Avg target
Bull Case
$47.79
+2,402.1%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$9.85
-80.6% from high
52-Week Low
$2.42
+-21.1% from low
Target vs 52W High
$42.64
+332.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%